Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Emerald Bioscience Inc (EMBI)

Emerald Bioscience Inc (EMBI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 31,929
  • Shares Outstanding, K 142,095
  • Annual Sales, $ 0 K
  • Annual Income, $ -19,190 K
  • 60-Month Beta -0.30
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.04
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/26/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2001 +9.95%
on 12/04/19
0.3350 -34.33%
on 11/21/19
-0.0610 (-21.71%)
since 11/08/19
3-Month
0.2001 +9.95%
on 12/04/19
0.4900 -55.10%
on 10/07/19
-0.0660 (-23.08%)
since 09/10/19
52-Week
0.2001 +9.95%
on 12/04/19
1.1700 -81.20%
on 04/09/19
-0.1196 (-35.22%)
since 12/10/18

Most Recent Stories

More News
Emerald Bioscience Inc. Announces Cannabidiol-Valine-Hemisuccinate Possesses Enhanced Anti-Seizure Activity when Compared with Cannabidiol (CBD) in the StemoniX Human Neural Tissue Platform

via NEWMEDIAWIRE -- Emerald Bioscience, Inc. (OTCQB: EMBI), a biopharmaceutical company focused on developing bioengineered cannabinoid-based therapeutics to address global medical indications, announced...

EMBI : 0.2200 (-2.09%)
Emerald Bioscience Announces $2.0 Million Registered Direct Offering

via NEWMEDIAWIRE -- Emerald Bioscience, Inc. (OTCQB: EMBI) ("Emerald"), a biopharmaceutical company focused on bioengineered cannabinoid-based therapeutics to address global medical indications, today...

EMBI : 0.2200 (-2.09%)
Emerald Bioscience to Present at Cowen 2nd Annual Boston Cannabis Conference

Emerald Bioscience, Inc. (OTCQB: EMBI), focused on the development of cannabinoid-based therapeutics to address global medical indications, especially those of unmet medical need, today announced that...

EMBI : 0.2200 (-2.09%)
Emerald Bioscience to Present Research Data Related to its Glaucoma Drug Candidate, NB1111, at 2019 American Association of Pharmaceutical Scientists

via NEWMEDIAWIRE -- Emerald Bioscience, Inc. (OTCQB: EMBI), focused on the development of cannabinoid-based therapeutics to address global medical indications, especially those of unmet medical need, today...

EMBI : 0.2200 (-2.09%)
Glauconix Presents Data Validating Impact of Emerald Bioscience's Prodrug on the Ocular Endocannabinoid System in Glaucoma

Study Points to Unique Link Between the Endocannabinoid System and the Inflammatory Cascade in the Eye

EMBI : 0.2200 (-2.09%)
Glauconix Biosciences and University of Mississippi to Present Research Data Related to Emerald Bioscience's Glaucoma Drug Candidate, NB1111, at 2019 American Academy of Ophthalmology Annual Meeting

via NEWMEDIAWIRE -- Emerald Bioscience, Inc. (OTCQB: EMBI), focused on the development of cannabinoid-based therapeutics to address global medical indications, especially those of unmet medical need, today...

EMBI : 0.2200 (-2.09%)
Emerald Bioscience to Participate in Investment and Scientific Conferences in September

via NEWMEDIAWIRE -- Emerald Bioscience, Inc. (OTCQB: EMBI), focused on the development of cannabinoid-based therapeutics to address global medical indications, especially those of unmet medical need, announced...

EMBI : 0.2200 (-2.09%)
Emerald Bioscience Appoints Chief Medical Officer and Executive Director, Clinical Operations

via NEWMEDIAWIRE -- Emerald Bioscience, Inc. (OTCQB: EMBI), focused on the development of cannabinoid-based therapeutics to address global medical indications, announced today the appointments of Dennis...

EMBI : 0.2200 (-2.09%)
Emerald Bioscience Starts Australian Operation Ahead of Planned Glaucoma Study

Pre-clinical studies of cannabidiol analog to commence

EMBI : 0.2200 (-2.09%)
Cannastocks2019 Investor Conference & Webinar Now Available for On-Demand Viewing

NEW YORK , May 17, 2019 /PRNewswire/ -- Virtual Investor Conferences, in partnership with Midtown Partners & Co, LLC, today announced that the presentations from the Cannastocks2019 Q1 Virtual...

SPR : 82.41 (-1.75%)
TGIF : N/A (unch)
CNPOF : 0.9691 (+0.95%)
FIRE.TO : 0.65 (-2.99%)
EMH.VN : 0.300 (-6.25%)
OGI.VN : 6.850 (-0.44%)
AXIM : 0.3900 (-9.30%)
EMBI : 0.2200 (-2.09%)
GSRX : 0.0500 (unch)
KSHB : 1.6100 (-1.83%)
MRMD : 0.6400 (+10.34%)
SRUTF : 0.1500 (-6.07%)
ACRGF : 5.3200 (-4.14%)
EMHTF : 0.2250 (-6.13%)
OGRMF : 8.3500 (+4.64%)
SPRWF : 0.4931 (-3.69%)
TGIFF : 0.1580 (+2.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade EMBI with:

Key Turning Points

2nd Resistance Point 0.2320
1st Resistance Point 0.2260
Last Price 0.2200
1st Support Level 0.2170
2nd Support Level 0.2140

See More

52-Week High 1.1700
Fibonacci 61.8% 0.7995
Fibonacci 50% 0.6851
Fibonacci 38.2% 0.5706
Last Price 0.2200
52-Week Low 0.2001

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar